全文获取类型
收费全文 | 2503篇 |
免费 | 92篇 |
国内免费 | 26篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 47篇 |
妇产科学 | 77篇 |
基础医学 | 337篇 |
口腔科学 | 45篇 |
临床医学 | 172篇 |
内科学 | 560篇 |
皮肤病学 | 41篇 |
神经病学 | 179篇 |
特种医学 | 64篇 |
外科学 | 491篇 |
综合类 | 18篇 |
预防医学 | 43篇 |
眼科学 | 71篇 |
药学 | 156篇 |
中国医学 | 4篇 |
肿瘤学 | 300篇 |
出版年
2023年 | 12篇 |
2022年 | 36篇 |
2021年 | 57篇 |
2020年 | 30篇 |
2019年 | 36篇 |
2018年 | 47篇 |
2017年 | 44篇 |
2016年 | 39篇 |
2015年 | 46篇 |
2014年 | 67篇 |
2013年 | 84篇 |
2012年 | 159篇 |
2011年 | 191篇 |
2010年 | 112篇 |
2009年 | 107篇 |
2008年 | 151篇 |
2007年 | 148篇 |
2006年 | 162篇 |
2005年 | 149篇 |
2004年 | 141篇 |
2003年 | 150篇 |
2002年 | 162篇 |
2001年 | 44篇 |
2000年 | 37篇 |
1999年 | 40篇 |
1998年 | 45篇 |
1997年 | 37篇 |
1996年 | 34篇 |
1995年 | 32篇 |
1994年 | 27篇 |
1993年 | 24篇 |
1992年 | 23篇 |
1991年 | 21篇 |
1990年 | 17篇 |
1989年 | 11篇 |
1988年 | 10篇 |
1987年 | 8篇 |
1986年 | 3篇 |
1985年 | 14篇 |
1984年 | 9篇 |
1983年 | 3篇 |
1982年 | 11篇 |
1981年 | 7篇 |
1980年 | 5篇 |
1979年 | 4篇 |
1978年 | 3篇 |
1977年 | 4篇 |
1974年 | 3篇 |
1965年 | 2篇 |
1937年 | 2篇 |
排序方式: 共有2621条查询结果,搜索用时 31 毫秒
81.
Shunji Hasegawa Takeshi Matsushige Hirofumi Inoue Midori Takahara Madoka Kajimoto Hiroshi Momonaka Chiemi Ishida Saya Tanaka Tsuneo Morishima Takashi Ichiyama 《Brain & development》2013
Background: Influenza-associated encephalopathy (IE) is a serious complication during influenza viral infection. Common clinical symptoms of IE include seizures and progressive coma with high-grade fever. We previously reported that hypercytokinemia and monocyte/macrophage activation may play an important role in the pathogenesis of IE. CD163 is a scavenger receptor for hemoglobin–haptoglobin complexes and is expressed by monocytes/macrophages. Proteolytic cleavage of monocyte-bound CD163 by matrix metalloproteinases releases soluble CD163 (sCD163). However, there have been no reports regarding serum sCD163 levels in IE patients. Methods: We measured serum levels of sCD163 as a marker of monocyte/macrophage activation in IE patients with poor outcomes, those without neurological sequelae, influenza patients without IE, and control subjects. Results: Serum sCD163 levels were significantly higher in IE patients with poor outcomes than in those without neurological sequelae. In particular, sCD163 levels in cases of death were significantly higher than those in other cases. Conclusions: Our results suggest that monocyte/macrophage activation is related to the pathogenesis of severe IE. 相似文献
82.
Manabu Okada Yoshihiro Tominaga Takayuki Yamamoto Takahisa Hiramitsu Shunji Narumi Yoshihiko Watarai 《World journal of surgery》2016,40(3):595-599
Background
Reoperative parathyroidectomy (RPTX) because parathyroid glands have been missed is frequently required in patients with secondary hyperparathyroidism (SHPT). The usual locations of these missed glands in patients with SHPT are yet to be fully elucidated.Methods
We retrospectively investigated the locations of missed glands in 165 patients who underwent RPTX for persistent or recurrent SHPT at our institution from August 1982 to July 2014. At our institution, total parathyroidectomy with forearm autograft is the routine operative procedure for SHPT. We also routinely resect the thymic tongue.Results
Of 165 patients, 82 underwent initial parathyroidectomy at our institution (Group A), and the remaining 83 underwent initial parathyroidectomy at other institutions (Group B). A total of 239 parathyroid glands were resected (Group A, 93; Group B, 146). Missed glands were most commonly located in the mediastinum (Group A, 22/93) and the thymic tongue (Group B, 31/146).Conclusions
In patients with persistent or recurrent SHPT, ectopic parathyroid glands are frequently located in the mediastinum and thymic tongue. Therefore, resecting the thymic tongue during the initial operation may reduce the need for RPTX.83.
Takayuki Yamamoto Yoshihiro Tominaga Manabu Okada Takahisa Hiramitsu Makoto Tsujita Norihiko Goto Shunji Narumi Yoshihiko Watarai 《World journal of surgery》2016,40(3):600-606
Background
Persistent hyperparathyroidism (HPT) after renal transplantation (RTx), termed tertiary HPT (THPT), is not uncommon. However, risk factors and appropriate operative procedures for THPT are poorly understood.Methods
A retrospective study of patients who underwent RTx without pre-transplant parathyroidectomy (PTx) was performed at our hospital between January 2001 and March 2011. Risk factors for the development of THPT were investigated by comparing THPT and non-THPT groups. We retrospectively analyzed patients with THPT who underwent total PTx with forearm autograft. Pre- and postoperative (1 year after PTx) laboratory results were analyzed for PTx efficacy.Results
Data for 520 patients were analyzed. On multivariate analysis, long dialysis duration (p = 0.009, hazard ratio (HR) 1.01), large maximum parathyroid gland size before RTx (p = 0.003, HR 1.23), pre-RTx high intact parathyroid hormone (iPTH) (p = 0.041, HR 1.01), post-RTx (<2 weeks) high calcium (Ca) (p < 0.001, HR 25.04), and post-RTx high alkaline phosphatase (ALP) (p = 0.027, HR 0.99) were identified as risk factors for THPT. Patients who underwent PTx showed significant improvement compared with baseline for serum Ca, phosphorus, iPTH, and ALP. Serum creatinine showed no significant difference.Conclusions
Several risk factors for THPT development were identified. PTx for patients with THPT significantly improved serum Ca, iPTH, ALP, and phosphorous levels. There was no significant difference in renal function after PTx. Therefore, total PTx with forearm autograft may be an appropriate surgical approach for patients with THPT.84.
Kokoro?KobayashiEmail author Yoshinori?Ito Masaaki?Matsuura Ippei?Fukada Rie?Horii Shunji?Takahashi Futoshi?Akiyama Takuji?Iwase Yasuo?Hozumi Yoshikazu?Yasuda Kiyohiko?Hatake 《Surgery today》2016,46(7):821-826
Purpose
Although improved long-term prognoses for patients with metastatic breast cancer (MBC) have been demonstrated, few reports address overall survival (OS) with sufficient follow-up. Furthermore, the relevance of immunohistological subtypes to OS in MBC has not been clarified.Methods
We evaluated, retrospectively, the OS of patients who had been initiated on systemic therapy for MBC between 2000 and 2008.Results
The subjects of this study were 527 patients with MBC treated by systemic therapy. The median survival time (MST) was 55.5 months. The MST for each immunohistological subtype was as follows: luminal, 59.9 months; luminal-HER2, not reached; triple-negative, 18.6 months; and HER2-enriched, 49.9 months. According to multivariate analysis, metastasis-free intervals of ≥2 years and treatment with anthracycline for MBC were predictive of better OS. The predictors of shorter OS included disease progression after first-line treatment for MBC, triple-negative, and all histological factors, except papillotubular carcinoma, with liver metastasis, and having three or more initial metastatic sites.Conclusions
The prognosis of the patients with MBC in this series was better than that reported before 2000, which is probably attributable to the use of novel, improved pharmacological agents. For example, luminal-HER2 tumors can be treated using both aromatase inhibitors and trastuzumab. Because of the lower toxicities, it is now possible to administer these agents for longer periods, resulting in better prognoses.85.
Kenta Ito Norihiko Goto Kenta Futamura Manabu Okada Takayuki Yamamoto Makoto Tsujita Takahisa Hiramitsu Shunji Narumi Yoshihiro Tominaga Yoshihiko Watarai 《Clinical and experimental nephrology》2016,20(2):309-315
Background
Some studies have reported causal associations between bacteremia and mortality or allograft loss in kidney transplant recipients (KTR). However, few studies have assessed the clinical course of kidney function and the risk of acute allograft rejection after bacteremia.Methods
We retrospectively reviewed 902 kidney transplants performed at Nagoya Daini Red Cross Hospital between January 1, 2002 and March 31, 2014. Forty-five living donor kidney transplant recipients with single bacteremia were included. We analyzed death, change in kidney function, and development of acute allograft rejection 12 months after bacteremia according to the following groups: primary source of bacteremia (urinary tract or other sources), site of acquisition (community acquired or nosocomial), severity (not meeting the systemic inflammatory response syndrome criteria and sepsis or severe sepsis and septic shock), empiric antibiotic use (appropriate or inappropriate), and baseline kidney function (estimated glomerular filtration rate ≤44.7 or ≥44.8 ml/min).Results
Urinary tract infection (UTI) was the leading cause of bacteremia (68.9 %), and Escherichia coli was the most common pathogen. Three cases (6.7 %) died of infection that caused bacteremia within 12 months. Pneumonia accounted for two-thirds. Kidney function declined 1 week after bacteremia (P < 0.05), particularly in severe cases. Thereafter, kidney function was comparable to baseline level in each group (P ≥ 0.05). Severe UTI was associated with subsequent acute allograft rejection (P = 0.03).Conclusions
Pneumonia in KTR should be managed with caution. Kidney function generally returned to baseline level after bacteremia. However, severe UTI may be associated with subsequent acute allograft rejection.86.
87.
88.
Kato Shunji Shiozaki Atsushi Kudou Michihiro Shimizu Hiroki Kosuga Toshiyuki Ohashi Takuma Arita Tomohiro Konishi Hirotaka Komatsu Shuhei Kubota Takeshi Fujiwara Hitoshi Okamoto Kazuma Kishimoto Mitsuo Konishi Eiichi Otsuji Eigo 《Annals of surgical oncology》2022,29(5):2944-2956
Annals of Surgical Oncology - Transient receptor potential vanilloid 2 (TRPV2) is a highly Ca2+-permeable ion channel that is involved in a number of cellular processes. It is expressed in various... 相似文献
89.
Fujitani Kazumasa Kurokawa Yukinori Takeno Atsushi Kawabata Ryohei Omori Takeshi Imamura Hiroshi Hirao Motohiro Endo Shunji Kawada Junji Moon Jeong Ho Kobayashi Noboru Takahashi Tsuyoshi Yamasaki Makoto Takiguchi Shuji Mori Masaki Eguchi Hidetoshi Doki Yuichiro 《Annals of surgical oncology》2022,29(2):933-934
Annals of Surgical Oncology - 相似文献
90.
Tsutomu Shimada Yuichiro Nakayama Yukiko Harasawa Hirofumi Matsui Hiroko Kobayashi Yoshimichi Sai Ken-ichi Miyamoto Shunji Tomatsu Masaki Aburada 《Journal of natural medicines》2014,68(4):668-676
Salacia reticulata Wight (S. reticulata) is a herbal medicine used for treatment of early diabetes in Ayurvedic medicine. In previous reports, the extract of S. reticulata showed preventive effects on obesity and various metabolic disorders and a suppressive effect on differentiation in premature adipocytes. The aim of this research was to elucidate the therapeutic efficacy of the extract of S. reticulata on obesity and various metabolic disorders in 12-week-old TSOD mice with obesity and metabolic disorders and in mature 3T3-L1 adipocytes. In TSOD mice, S. reticulata therapy produced a reduction in body weight and mesenteric fat accumulation, an improvement in abnormal glucose metabolism, and an increase in adiponectin level in plasma. In addition, the mRNA expressions of hormone-sensitive lipase (HSL) and adiponectin were increased in mesenteric fat. In in vitro experiments, S. reticulata therapy produced suppression of intracellular triacylglycerol accumulation and enhancement of glycerol release into the medium in mature 3T3-L1 cells. The mRNA expressions of lipogenesis factor (peroxisome proliferator-activated receptor γ, lipoprotein lipase, CD36, and fatty acid binding protein 4) were down-regulated, while the expressions of lipolysis factor (adipose tissue triacylglycerol lipase and HSL) and adiponectin were up-regulated. Moreover, the extract of S. reticulata enhanced the expression of total AMP-activated protein kinase α (AMPKα) and phosphorylated AMPKα in mature adipocytes. These findings demonstrate that the extract of S. reticulata has therapeutic effects on obesity and metabolic disorders by enhancing lipogenesis genes and suppressing lipolysis genes through the activation of AMPKα in adipocytes. 相似文献